Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases

Eur J Intern Med. 2023 Sep:115:137-139. doi: 10.1016/j.ejim.2023.06.014. Epub 2023 Jun 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Rheumatic Diseases* / drug therapy
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines